PUBMED FOR HANDHELDS

Journal Abstract Search


173 related items for PubMed ID: 15378419

  • 21. Protracted levamisole in children with frequent-relapse nephrotic syndrome.
    Ginevri F, Trivelli A, Ciardi MR, Ghiggeri GM, Parfumo F, Gusmano R.
    Pediatr Nephrol; 1996 Aug; 10(4):550. PubMed ID: 8865269
    [No Abstract] [Full Text] [Related]

  • 22. Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome.
    Ekambaram S, Mahalingam V, Nageswaran P, Udani A, Geminiganesan S, Priyadarshini S.
    Indian Pediatr; 2014 May; 51(5):371-3. PubMed ID: 24953577
    [Abstract] [Full Text] [Related]

  • 23. Levamisole in relapsing steroid-sensitive nephrotic syndrome: where do we stand?
    Kemper MJ, Neuhaus TJ.
    Kidney Int; 2018 Feb; 93(2):310-313. PubMed ID: 29389398
    [Abstract] [Full Text] [Related]

  • 24. Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children.
    Dayal U, Dayal AK, Shastry JC, Raghupathy P.
    Nephron; 1994 Feb; 66(4):408-12. PubMed ID: 8015643
    [Abstract] [Full Text] [Related]

  • 25. Distinctive vasculopathy with systemic involvement due to levamisole long-term therapy: a case report.
    Aoun B, Alali M, Degheili JA, Sanjad S, Vaquin C, Donadieu J, Ulinski T, Termos S.
    J Med Case Rep; 2018 Jul 16; 12(1):209. PubMed ID: 30008268
    [Abstract] [Full Text] [Related]

  • 26. Levamisole in Children with Idiopathic Nephrotic Syndrome: Clinical Efficacy and Pathophysiological Aspects.
    Mühlig AK, Lee JY, Kemper MJ, Kronbichler A, Yang JW, Lee JM, Shin JI, Oh J.
    J Clin Med; 2019 Jun 16; 8(6):. PubMed ID: 31208104
    [Abstract] [Full Text] [Related]

  • 27. Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.
    Hafeez F, Ahmed TM, Samina U.
    J Coll Physicians Surg Pak; 2006 Jan 16; 16(1):35-7. PubMed ID: 16441986
    [Abstract] [Full Text] [Related]

  • 28. [Immunity and immunosuppression in childhood idiopathic nephrotic syndrome].
    Frange P, Frey MA, Deschênes G.
    Arch Pediatr; 2005 Mar 16; 12(3):305-15. PubMed ID: 15734130
    [Abstract] [Full Text] [Related]

  • 29. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
    Alsaran K, Grisaru S, Stephens D, Arbus G.
    Clin Nephrol; 2001 Oct 16; 56(4):289-94. PubMed ID: 11680658
    [Abstract] [Full Text] [Related]

  • 30. [Levamisole in children with frequently recurring idiopathic nephrotic syndrome].
    Meregalli P, Bianchetti MG, Imoberdorf G, Lütschg J, Reymond D, Oetliker OH.
    Schweiz Med Wochenschr; 1994 May 14; 124(19):801-5. PubMed ID: 8209202
    [Abstract] [Full Text] [Related]

  • 31. Levamisole therapy in nephrotic syndrome.
    Srivastava RN.
    Pediatr Nephrol; 1999 Sep 14; 13(7):636. PubMed ID: 10507834
    [No Abstract] [Full Text] [Related]

  • 32. Levamisole in children's idiopathic nephrotic syndrome.
    La Manna A, Polito C, Del Gado R, Foglia AC.
    Child Nephrol Urol; 1999 Sep 14; 9(4):200-2. PubMed ID: 3255483
    [Abstract] [Full Text] [Related]

  • 33. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
    Donia AF, Amer GM, Ahmed HA, Gazareen SH, Moustafa FE, Shoeib AA, Ismail AM, Khamis S, Sobh MA.
    Pediatr Nephrol; 2002 May 14; 17(5):355-8. PubMed ID: 12042893
    [Abstract] [Full Text] [Related]

  • 34. Steroid-sensitive nephrotic syndrome: from childhood to adulthood.
    Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Grünfeld JP, Niaudet P.
    Am J Kidney Dis; 2003 Mar 14; 41(3):550-7. PubMed ID: 12612977
    [Abstract] [Full Text] [Related]

  • 35. [Levamisole in the treatment of nephrotic syndrome].
    García Soto L, Miranda Romera P, Vintimilla Andrade JE, Gómez Llorente MA, de Diego Fernández P.
    An Pediatr (Engl Ed); 2020 Mar 14; 92(3):168-169. PubMed ID: 31151760
    [No Abstract] [Full Text] [Related]

  • 36. [Treatments of steroid-dependent nephrotic syndrome in children].
    Couderc A, Bérard E, Guigonis V, Vrillon I, Hogan J, Audard V, Baudouin V, Dossier C, Boyer O.
    Arch Pediatr; 2017 Dec 14; 24(12):1312-1320. PubMed ID: 29146214
    [Abstract] [Full Text] [Related]

  • 37. Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome.
    Barbano G, Ginevri F, Ghiggeri GM, Gusmano R.
    Pediatr Nephrol; 1999 Sep 14; 13(7):602-3. PubMed ID: 10460511
    [Abstract] [Full Text] [Related]

  • 38. Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. British Association for Paediatric Nephrology.
    Lancet; 1991 Jun 29; 337(8757):1555-7. PubMed ID: 1675705
    [Abstract] [Full Text] [Related]

  • 39. Levamisole in steroid-sensitive nephrotic syndrome: usefulness in adult patients and laboratory insights into mechanisms of action via direct action on the kidney podocyte.
    Jiang L, Dasgupta I, Hurcombe JA, Colyer HF, Mathieson PW, Welsh GI.
    Clin Sci (Lond); 2015 Jun 29; 128(12):883-93. PubMed ID: 25626449
    [Abstract] [Full Text] [Related]

  • 40. Management of steroid sensitive nephrotic syndrome: revised guidelines.
    Indian Pediatric Nephrology Group, Indian Academy of PediatricsDepartment of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India. arvindbagga@hotmail.com, Bagga A, Ali U, Banerjee S, Kanitkar M, Phadke KD, Senguttuvan P, Sethi S, Shah M.
    Indian Pediatr; 2008 Mar 29; 45(3):203-14. PubMed ID: 18367765
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.